Zhejiang DiAn Diagnostics Co (300244) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥594.17 Million ≈ $86.95 Million USD) by net assets (CN¥8.67 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang DiAn Diagnostics Co (300244) total market value for the company's overall valuation and market capitalisation.

Zhejiang DiAn Diagnostics Co - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Zhejiang DiAn Diagnostics Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang DiAn Diagnostics Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their cash flow conversion efficiency. Explore 300244 cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Kfin Technologies Limited
NSE:KFINTECH
0.108x
Ennoconn Corp
TW:6414
0.002x
Ola Electric Mobility Ltd
NSE:OLAELEC
-0.066x
CJ Cheiljedang
KO:097950
0.045x
Carabao Group Public Company Limited
BK:CBG
0.036x
Guangzhou SiE Consulting Co Ltd
SHE:300687
0.006x
Sichuan Anning Iron and Titanium Co
SHE:002978
-0.068x
Vivendi SA
PA:VIV
-0.007x

Annual Cash Flow Conversion Efficiency for Zhejiang DiAn Diagnostics Co (2008–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang DiAn Diagnostics Co from 2008 to 2025. View Zhejiang DiAn Diagnostics Co stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.60 Billion
≈ $1.26 Billion
CN¥2.03 Billion
≈ $296.81 Million
0.236x +71.17%
2024-12-31 CN¥8.77 Billion
≈ $1.28 Billion
CN¥1.21 Billion
≈ $176.68 Million
0.138x -29.01%
2023-12-31 CN¥9.90 Billion
≈ $1.45 Billion
CN¥1.92 Billion
≈ $281.15 Million
0.194x +12.44%
2022-12-31 CN¥9.50 Billion
≈ $1.39 Billion
CN¥1.64 Billion
≈ $239.89 Million
0.173x -2.13%
2021-12-31 CN¥7.48 Billion
≈ $1.09 Billion
CN¥1.32 Billion
≈ $192.85 Million
0.176x -31.31%
2020-12-31 CN¥6.03 Billion
≈ $882.20 Million
CN¥1.55 Billion
≈ $226.41 Million
0.257x +172.91%
2019-12-31 CN¥5.14 Billion
≈ $751.88 Million
CN¥483.19 Million
≈ $70.71 Million
0.094x +18.49%
2018-12-31 CN¥4.70 Billion
≈ $688.18 Million
CN¥373.24 Million
≈ $54.62 Million
0.079x +507.28%
2017-12-31 CN¥2.95 Billion
≈ $431.21 Million
CN¥38.51 Million
≈ $5.64 Million
0.013x -74.84%
2016-12-31 CN¥2.55 Billion
≈ $372.55 Million
CN¥132.25 Million
≈ $19.35 Million
0.052x -58.11%
2015-12-31 CN¥1.06 Billion
≈ $154.94 Million
CN¥131.29 Million
≈ $19.21 Million
0.124x -26.22%
2014-12-31 CN¥701.84 Million
≈ $102.70 Million
CN¥117.95 Million
≈ $17.26 Million
0.168x +31.39%
2013-12-31 CN¥589.81 Million
≈ $86.31 Million
CN¥75.44 Million
≈ $11.04 Million
0.128x +162.88%
2012-12-31 CN¥527.32 Million
≈ $77.16 Million
CN¥25.66 Million
≈ $3.75 Million
0.049x +14.88%
2011-12-31 CN¥477.04 Million
≈ $69.81 Million
CN¥20.20 Million
≈ $2.96 Million
0.042x -83.57%
2010-12-31 CN¥159.92 Million
≈ $23.40 Million
CN¥41.23 Million
≈ $6.03 Million
0.258x +601.12%
2009-12-31 CN¥110.32 Million
≈ $16.14 Million
CN¥4.06 Million
≈ $593.57K
0.037x +127.90%
2008-12-31 CN¥27.86 Million
≈ $4.08 Million
CN¥-3.67 Million
≈ $-537.24K
-0.132x --

About Zhejiang DiAn Diagnostics Co

SHE:300244 China Diagnostics & Research
Market Cap
$1.74 Billion
CN¥11.88 Billion CNY
Market Cap Rank
#6709 Global
#1376 in China
Share Price
CN¥19.01
Change (1 day)
+3.15%
52-Week Range
CN¥14.54 - CN¥29.50
All Time High
CN¥46.17
About

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more